Rabbit Recombinant Monoclonal SLAP2 antibody. Carrier free. Suitable for ICC/IF, IP, WB, Flow Cyt (Intra) and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
ICC/IF | IP | IHC | WB | Flow Cyt (Intra) | |
---|---|---|---|---|---|
Human | Tested | Tested | Not recommended | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Adapter protein, which negatively regulates T-cell receptor (TCR) signaling. Inhibits T-cell antigen-receptor induced activation of nuclear factor of activated T-cells. May act by linking signaling proteins such as ZAP70 with CBL, leading to a CBL dependent degradation of signaling proteins.
C20orf156, SLAP2, SLA2, Src-like-adapter 2, Modulator of antigen receptor signaling, Src-like adapter protein 2, MARS, SLAP-2
Rabbit Recombinant Monoclonal SLAP2 antibody. Carrier free. Suitable for ICC/IF, IP, WB, Flow Cyt (Intra) and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
ab249590 is the carrier-free version of Anti-SLAP2 antibody [EPR8083(2)] ab170918.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Src-like adapter protein 2 (SLAP2) also known as SLAP2 functions as an adaptor protein involved in signal transduction. It mediates interactions between membrane receptors and intracellular signaling components. SLAP2 is a protein of approximately 32 kDa and expression levels vary across different tissues including high expression in immune cells such as lymphocytes and macrophages. The protein has SH2 and SH3 domains which allow it to bind to phosphorylated tyrosines on its target proteins facilitating their degradation or modification.
SLAP2 has a major role in regulating the immune response. By forming complexes with the components of the signal transduction machinery SLAP2 modulates the activity of key receptors such as the T-cell receptor (TCR) and B-cell receptor (BCR). These interactions influence cellular responses such as proliferation differentiation and apoptosis. Through its action SLAP2 acts as a negative regulator preventing overactivation of immune responses and maintaining homeostasis.
Studies have shown that SLAP2 participates in both the T-cell receptor signaling pathway and the B-cell receptor signaling pathway. In these pathways SLAP2 interacts with kinases associated with these receptors such as Lck and Fyn influencing downstream signaling events. SLAP2 can inhibit excessive activation of these pathways by promoting the degradation of key signaling molecules ensuring that cells respond appropriately to external signals during immune activation.
SLAP2 has been linked to certain types of cancer and autoimmune diseases. For example alterations in SLAP2 expression or function may contribute to lymphomas where disrupted signaling processes lead to uncontrolled cell growth. In autoimmune diseases aberrant SLAP2 activity could result in improper immune cell activation potentially linked to proteins like ZAP-70 which are also involved in disease modulation. Understanding SLAP2's regulation and interaction with signaling proteins could offer insights for therapeutic interventions in these conditions.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-SLAP2 antibody [EPR8083(2)] ab170918&
44; the same antibody clone in a different buffer formulation.
All lanes: Immunoprecipitation - Anti-SLAP2 antibody [EPR8083(2)] (Anti-SLAP2 antibody [EPR8083(2)] ab170918) at 1/1000 dilution
Lane 1: Immunoprecipitation pellet from Jurkat cell lysate using Anti-SLAP2 antibody [EPR8083(2)] ab170918 at 1/10
Lane 2: Immunoprecipitation pellet from 1X PBS using Anti-SLAP2 antibody [EPR8083(2)] ab170918 at 1/10 (negative control)
All lanes: HRP-conjugated anti-rabbit IgG preferentially detecting the non-reduced form of rabbit IgG
Developed using the ECL technique.
Predicted band size: 29 kDa
This data was developed using Anti-SLAP2 antibody [EPR8083(2)] ab170918, the same antibody clone in a different buffer formulation.
Intracellular flow cytometric analysis of permeabilized Jurkat cells labeling SLAP2 with Anti-SLAP2 antibody [EPR8083(2)] ab170918 at 1/100 (red) or a rabbit IgG (negative) (green).
This data was developed using Anti-SLAP2 antibody [EPR8083(2)] ab170918, the same antibody clone in a different buffer formulation.Immunofluorescent analysis of Jurkat cells labeling SLAP2 with Anti-SLAP2 antibody [EPR8083(2)] ab170918 at 1/100 (green). DAPI nuclear staining (blue).
This data was developed using Anti-SLAP2 antibody [EPR8083(2)] ab170918, the same antibody clone in a different buffer formulation.
All lanes: Western blot - Anti-SLAP2 antibody [EPR8083(2)] (Anti-SLAP2 antibody [EPR8083(2)] ab170918) at 1/1000 dilution
All lanes: Jurkat cell lysate at 10 µg
All lanes: Goat anti-rabbit HRP conjugated antibody at 1/2000 dilution
Developed using the ECL technique.
Predicted band size: 29 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com